“…Three approaches are reviewed here. The first involves drug-eluting structures formulated with anti-inflammatory drugs [21,22,23,24,25] and neurotrophin-eluting hydrogels [26,27,28,29,30,31]. The second approach involves integration of microfluidic channels into neural prostheses for in situ delivery of bioactive molecules with high temporal and spatial resolution [32,33,34,35,36,37,38,39].…”